View More View Less
  • 1 ELTE Személyiség- és Egészségpszichológia Tanszék Budapest
  • | 2 ELTE Élettani és Neurobiológiai Tanszék Budapest
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $204.00

Áttekintésünk célja a nocebo-jelenség átfogó ismertetése, valamint három, a szakirodalomban rendszerint különállóként kezelt jelenségkör (nocebo, egészséges személyek tünetbeszámolója, orvosilag nem megmagyarázott panaszok) rövid összehasonlítása. Elméletünk szerint e jelenségek között a kiváltó és fenntartó mechanizmusok szintjén annyira szoros a rokonság, hogy tárgyalásuk egységes fogalmi keretben (nem-specifikus egészségproblémák) lenne indokolt.Ennek bizonyítására áttekintjük a jelenségek mögött álló potenciális pszichofiziológiai mechanizmusokat (az elvárások különböző típusai; klasszikus kondicionálás; társas tanulás; stressz, szorongás, depresszió; szomatizáció; a tabletták anyaga; valós betegségek tünetei) és motivációs hátteret (kontrolligény és hibás oktulajdonítás; gyógyszerek hatásosságának megítélése; terápiás rezisztencia; bűntudat és önbüntetés; tömegjelenségek; másodlagos betegségelőnyök; tudatos szimuláció), illetve a fontosabb kapcsolódó diszpozicionális személyiségjellemzőket (női nem; neuroticizmus; testi folyamatok fokozott észrevételére való hajlam).Röviden összehasonlítjuk a nocebo- és a placebo-jelenséget, és ellenezzük azt a megközelítést, ami a kettőt egymás tükörképének tekinti.Végül összefoglaljuk és kiegészítjük a korábbi irodalomban található, a nocebo-hatás csökkentését célzó intervenciós lehetőségeket.

  • Abramson , H. A., Jarvik , M. E., Levine , A., Kaufman , M. R., Hirsch , M. W. (1955) Lysergic Acid diethylamide (LSD-25): XV. The effects produced by substitution of a tap water placebo. The Journal of Psychology, 40, 367–383.

  • Ádám , Gy. (1998) Visceral perception: Understanding Internal Cognition . Plenum Press, New York

  • AlAbsi , M., Rokke , P. D. (1991) Can anxiety help us tolerate pain? Pain, 46, 43–51.

  • Andrykowski , M. A., Jacobsen , P. B., Marks , E., Gorfinkle , K., Hakes , T. B., Kaufman , R. J., Currie , V. E., Holland , J. C., Redd , W. H. (1988) Prevalence, predictors, and course of anticipatory nausea in women receiving adjuvant chemotherapy for breast cancer. Cancer, 62, 2607–2613.

  • Andrykowski , M. A., Redd , W. H. (1987) Longitudinal Analysis of the Development of Anticipatory Nausea. Journal of Consulting and Clinical Psychology, 55, 36–41.

  • Avery , C. W., Ibelle , B. P., Allison , B., Mandell , N. (1967) Systematic errors in the evaluation of side effects. The American Journal of Psychiatry, 123, 875–878.

  • Bárdos , Gy ., Balassa , T., Elek , Sz ., Szemerszky , R., Polyák , Á. (2006) Animal models of non-specific health problems caused by low-frequency electromagnetic field exposure. FENS Abstracts, 3, A129.2.

  • BárdosGy . (2003) Viselkedés-élettan. I.: Pszichovegetatív kölcsönhatások . Scolar, Budapest

  • Bárdos , Gy ., Balassa , T., Szemerszky , R., Polyák , Á. (2007) Non-specific effects of electro-magnetic fields: Animal models? Clinical Neuroscience, 60 (S1), 9–10.

  • Barefoot , J. C., Girodo , M. (1972) The misattribution of smoking cessation symptoms. Canad. Journal Behav. Sci./Rev. Canad. Sci. Comp., 4 (4), 358–363.

  • Barsky , A. J. (1979) Patients who amplify bodily sensations. Annals of Internal Medicine, 91, 63–70.

  • Barsky , A. J. (1983) Nonpharmacologic aspects of medication. Archives of Internal Medicine, 143, 1544–1548.

  • Barsky , A. J., Borus , J. F. (1999) Functional Somatic Syndromes. Annals of Internal Medicine, 130, 910–921.

  • Barsky , A. J., Goodson , J. D., Lane , R. S., Cleary , P. D. (1988) The amplification of somatic symptoms. Psychosomatic Medicine, 50, 510–519.

  • Barsky , A. J., Rogers , M. P., Borus , J. F. (2002) When are medication side effects due to the nocebo phenomenon? Reply. Journal of the American Medical Association, 287 (19), 2503–2504.

  • Barsky , A. J., Saintfort , R., Rogers , M. P., Borus , J. (2002) Nonspecific medication side effects and the nocebo phenomenon. Journal of the American Medical Association, 287 (5), 622–627.

  • Barsky , A. J., Saintfort , R., Rogers , M. P., Borus , J. F. (2004) Nonspecific medication side effects and the nocebo phenomenon. Science and Engineering Ethics, 10, 133–134.

  • Beecher , H. K. (1955) The powerful placebo. Journal of the American Medical Association, 159, 1602–1606.

  • Benedetti , F., Amanzio , M. (1997) The neurobiology of placebo analgesia: from endogenous opioids to cholecystokinin. Progress in Neurobiology, 51, 109–125.

  • Benedetti , F., Amanzio , M., Casadio , C., Oliaro , A., Maggi , G. (1997) Blockade of nocebo hyperalgesia by cholecystokinin antagonist proglumide. Pain, 71, 135–140.

  • Benedetti , F., Amanzio , M., Vighetti , S., Asteggiano , G. (2006) The Biochemical and Neuroendocrine Bases of the Hyperalgesic Nocebo Effect. The Journal of Neuroscience, 26, 12014–12022.

  • Benedetti , F., Lanotte , M., Lopiano , L., Colloca , L. (2007) When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience, 147, 260–271.

  • Benedetti , F., Pollo , A., Lopiano , L., Lanotte , M., Vighetti , S., Rainero , I. (2003) Conscious expectation and unconscious conditioning in analgesic; motor and hormonal placebo/nocebo responses. The Journal of Neuroscience, 23, 4315–4323.

  • Benson , H. (1997) The nocebo effect: history and physiology. Preventive Medicine, 26, 612–615.

  • Berthelot , J.-M., Maugars , Y., Abgrall , M., Prost , A. (2001) Interindividual variations in beliefs about the placebo effect: a study in 300 rheumatology inpatients and 100 nurses. Joint Bone Spine, 68, 65–70.

  • Blackwell , B., Bloomfield , S. S., Buncher , C. R. (1972) Demonstration to medical students of placebo responses and non-drug factors. Lancet, 763 (1), 1279–1282.

  • Bootzin , R. R., Baile Y, E. T. (2005) Understanding Placebo, Nocebo, and Iatrogenic Treatment Effects. Journal of Clinical Psychology, 61, 871–880.

  • Bradley , G. W. (1978) Self-Serving Biases in the Attribution Process: A Reexamination of the Fact or Fiction Question. Journal of Personality and Social Psychology, 36 (1), 56–71.

  • Brody , H. (2000) The placebo response . Harper Collins, New York

  • Brown , R. J. (2006) Medically unexplained symptoms: a new model. Psychiatry, 5, 43–47.

  • Brown , R. S., Lees -Haley , P. R. (1992) Fear of future illness, chemical aids, and cancerophobia: a review. Psychological Reports, 71, 187–207.

  • Buss , A. H. (1980) Self-consciousness and social anxiety . W. H. Freeman & Co, San Francisco

  • Butler , C., Steptoe , A. (1986) Placebo Responses: An Experimental Study of Psychophysiological Processes in Asthmatic Volunteers. British Journal of Clinical Psychology, 25, 173–183.

  • Carver , C., Scheier , M. (1981) Attention and self-regulation . Springer, New York

  • Casper , R. C., Tollefson , G. D., Nilsson , M. E. (2001) No Gender Differences in Placebo Responses of Patients with Major Depressive Disorder. Biological Psychiatry, 49, 158–160.

  • Cioffi , D. (1991) Beyond attentional strategies: a cognitive-perceptual model of somatic interpretation. Psychological Bulletin, 109, 25–41.

  • Cluff , L. E., Thornton , G. F., Seidl , L. G. (1964) Studies on the epidemiology of adverse drug reactions. Journal of the American Medical Association, 188, 976–983.

  • Colloca , L., Benedetti , F. (2007) Nocebo hyperalgesia: how anxiety is turned into pain. Current Opinion in Anaesthesiology, 20, 435–439.

  • Colloca , L., Vighetti , S., Sigaudo , M., Benedetti , F. (2007) Hyperalgesic and allodynic effects of nocebo suggestions. European Journal of Pain, 11 (S1), S59–S20.

  • Costa , P. T., McCrae , R. R. (1987) Neuroticism, somatic complaints, and disease: is the bark worse than the bite? Journal of Personality, 55, 299–316.

  • Cox , T., Thirlawa Y, M., Gotts , G., Cox , S. (1983) The nature and assessment of general well-being. Journal of Psychosomatic Research, 27, 353–359.

  • Dahan , R., Caulin , C., Figea , L., Kanis , J. A., Caulin , F., Segrestaa , J. M. (1986) Does informed consent influence therapeutic outcome? A clinical trial of the hypnotic activity of placebo in patients admitted to hospital. British Medical Journal, 293, 363–364.

  • Davis , C., Ralevski , E., Kennedy , S. H., Neitzert , C. (1967) The role of personality factors in the reporting of side effect complaints to moclobemide and placebo. Journal of Consulting and Clinical Psychology, 31, 71–76.

  • Davis , C., Ralevski , E., Kennedy , S. H., Neitzert , C. (1995) The Role of Personality Factors in the Reporting of Side Effect Complaints to Moclobemide and Placebo: A Study of Healthy Male and Female Volunteers. Journal of Clinical Psychopharmacology, 15 (5), 347–352.

  • DeCharms , R. (1968) Personal causation: The internal affective determinants of behavior . Academic Press, New York

  • Dhume , V. G., Agshikar , N. V., Diniz , R. S. (1975) Placebo-induced side-effects in healthy volunteers. Clinician, 39, 289–290.

  • Diehl , H. S. (1933) Medical treatment of the common cold. Journal of the American Medical Association, 101, 2042–2049.

  • Downing , R. W., Rickels , K. (1967) Self-report of hostility and the incidence of side reactions in neurotic outpatients treated with tranquilizing drugs and placebo. Journal of Consulting Psychology, 31 (1), 71–76.

  • Drici , M. D., Raybaud , F., DeLunardo , C., Iacono , P., Gustovic , P. (1995) Influence of the behavior pattern on the nocebo response of healthy volunteers. British Journal of Clinical Pharmacology, 39, 204–206.

  • Duncan , J. W., Laird , J. D. (1980) Positive and Reverse Placebo Effects as a Function of Differences in Cues Used in Self-Perception. Journal of Personality and Social Psychology, 39 (6), 1024–1036.

  • Eikelboom , R., Stewart , J. (1982) Conditioning of drug-induced physiological responses. Psychological Review, 89, 507–528.

  • Engel , Jr . C. C., Adkins , J. A., Cowan , D. N. (2002) Caring for medically unexplained physical symptoms after toxic environmental exposures: effects of contested causation. Environmental Health Perspectives, 10 (Suppl 4), 641–647.

  • Evans , R. W. (2003) The Non-nocebo Response: Can Migraine Medication Efficacy Be Enhanced? Headache: The Journal of Head and Face Pain, 43, 693.

  • Evans , R. W., Rogers , M. P. (2003) Headaches and the Nocebo Effect. Headache, 43, 1113–1115.

  • Ferguson , J. M. (1993) Alprazolam XR: patient acceptability, safety, and tolerability. Psychiatric Annals, 23, 20–26.

  • Fisher , S., Fisher , R. L. (1963) Placebo response and acquiescence. Psychopharmacologia, 4, 298–301.

  • Flaten , M. A., Simonsen , T., Olsen , H. (1999) Drug-related information generates placebo and nocebo responses that modify the drug response. Psychosomatic Medicine, 61, 250–255.

  • Flaten , M. A., Simonsen , T., Waterloo , K., Olsen , H. (1997) Pharmacological classical conditioning in humans. Human Psychopharmacology – Clinical and Experimental, 12 (4), 369–377.

  • Geers , A. L., Helfer , S. G., Kosbab , K., Weiland , P., Landry , S. J. (2005) Reconsidering the role of personality in placebo effects: Dispositional optimism, situational expectations, and the placebo response. Journal of Psychosomatic Research, 58, 121–127.

  • Geers , A. L., Helfer , S. G., Weiland , P., Kosbab , K. (2006) Expectations and Placebo Response: A Laboratory Investigation into the Role of Somatic Focus. Journal of Behavioral Medicine, 29 (2), 171–178.

  • Geers , A. L., Weiland , P. E., Kosbab , K., Landry , S. J., Helfer , S. G. (2005) Goal activation, expectations, and the placebo effect. Journal of Personality and Social Psychology, 89, 143–159.

  • Glaser , E. M. (1953) Experiments on the side effects of drugs. British Journal of Pharmacology, 8, 187–192.

  • Glaser , E. M., Whittow , G. C. (1953) Evidence for a non-specific mechanism of habituation. Journal of Physiology, 122, 43P–44P.

  • Gliedman , L. H., Gantt , H. W., Teitelbaum , H. A. (1957) Some implications of conditional reflex studies for placebo research. American Journal of Psychiatry, 113, 1103–1107.

  • Golomb , B. A. (1995) Paradox of placebo effect. Nature, 375, 530.

  • Golomb , B. A. (1996) Using placebos. Nature, 379, 765.

  • Golomb , B. A. (2002) When are medication side effects due to the nocebo phenomenon? Letter to the editor. Journal of the American Medical Association, 287 (19), 2502–2503.

  • Gowdey , C. W., Hamilton , J. T., Philp , R. B. (1967) A controlled clinical trial using placebos in normal subjects: a teaching exercise. Canadian Medical Association Journal, 96, 1317–1322.

  • Green , D. M. (1962) Side effects. Federation Proceedings, 21, 179.

  • Green , D. M. (1964) Pre-existing conditions, placebo reactions, and “side effects.” Annals of Internal Medicine, 60, 255–265.

  • Greiner , T., Gold , H., Cattel , M., Travel , J., Bakst , H., Rinzler , S. H. et al. (1950) A method for the evaluation of the effects of drugs on cardiac pain in patients with angina of effort. The American Journal of Medicine, 9, 143–155.

  • Hankoff , L. D., Freedman , N., Engelhardt , D. M. (1960) Placebo responses in schizophrenic outpatients. Archives of General Psychiatry, 2, 33–42.

  • Hebb , A. L. O., Poulin , J.-F., Roach , S. P., Zacharko , R. M., Drolet , G. (2005) Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29, 1225–1238.

  • Heider , F. (1958) The psychology of interpersonal relations . Wiley, New York

  • Honigfeld , G. (1964) Non-specific factors in treatment. I. Review of placebo reactions and placebo reactors. Diseases of the Nervous System, 25, 145–155.

  • Howland , J. S., Baker , M. G., Poe , T. (1990) Does patient education cause side effects? Controlled trial. Journal of Family Practice, 31, 62–64.

  • Jensen , M. P., Karoly , P. (1991) Motivation and Expectancy Factors in Symptom Perception: A Laboratory Study of the Placebo Effect. Psychosomatic Medicine, 53, 144–152.

  • Jewett , D. L., Fein , G., Greenberg , M. H. (1990) A double-blind study of symptom provocation to determine food sensitivity. The New England Journal of Medicine, 323, 429–433.

  • Kast , E. C., Loesch , J. (1961) Influence of the doctor-patient relationship on drug action. Illinois Medical Journal, 119, 390–393.

  • Keeley , R. (2002) When are medication side effects due to the nocebo phenomenon? Letter to the editor. Journal of the American Medical Association, 287 (19), 2503.

  • Kelley , H. H. (1973) The processes of causal attribution. American Psychologist, 28, 107–128.

  • Kennedy , W. P. (1961) The nocebo reaction. Medical World, 1961, 203–205.

  • Keown , C., Slovic , P., Lichtenstein , S. (1984) Attitudes of physicians, pharmacists and laypersons towards seriousness and need for disclosure of prescription drug side-effects. Health Psychology, 3, 1–11.

  • Kirsch , I. (1985) Response expectancy as a determinant of experience and behavior. American Psychologist, 40, 1189–1202.

  • Kirsch , I. (1997) Specifying Nonspecifics: Psychological Mechanisms of Placebo Effects. In Harrington , A. (ed.) The placebo effect. An interdisciplinary exploration . 166–186. Harvard University Press, Cambridge

  • Knowles , J. B., Lucas , C. J. (1960) Experimental studies of the placebo response. Journal of Mental Science, 106, 231–240.

  • Köteles F., BárdosGy . (2007) Tabletták várt hatása és színe/mérete közötti kapcsolatok. Mentálhigiéné és Pszichoszomatika, 8 (4), 277–290.

  • Köteles F., BárdosGy . (2008a) Placebo és személyiség – a primitívtől a megküzdőig. I. A placebo-reszponder személyiség. Pszichológia, 28 (3), 267–285.

  • Köteles F., BárdosGy . (2008b) Placebo és személyiség – a primitívtől a megküzdőig. II. Szituáció, emóció, motiváció, attribúció és megküzdés. Pszichológia, 28 (4), 339–356.

  • Köteles F., BárdosGy . (2009) Tabletták perceptuális jellemzői által generált mellékhatás-elvárások és pszichológiai hátterük. Mentálhigiéné és Pszichoszomatika, 10 (1), 47–62.

  • Köteles F., Fodor D., Cziboly Á., BárdosGy . (2007) A placebo terápiás felhasználásának etikai kérdései. Magyar Pszichológiai Szemle, 62 (4), 429–448.

  • Kradin , R. (2004) The placebo response – its putative role as a functional salutogenic mechanism of the central nervous system. Perspectives in Biology and Medicine, 47, 328–338.

  • Kradin , R. (2008) The placebo response and the power of unconscious healing . Routledge, New York–London

  • KulcsárZs ., Rózsa S., KökönyeiGy ., szerk. (2004) Megmagyarázhatatlan testi tünetek. Szomatizáció és funkcionális stresszbetegségek. I–II. ELTE Eötvös Kiadó, Budapest

  • Kunda , Z. (1990) The case for motivated reasoning. Psychological Bulletin, 108, 480–498.

  • Lang , E. V., Hatsiopoulou , O., Koch , T., Berbaum , K., Lutgendorf , S., Kettenmann , E., Logan , H., Kaptchuk , T. J. (2005) Can words hurt? Patient-provider interactions during invasive procedures. Pain, 114, 303–309.

  • Lasagna , L., Mosteller , F., von Felsinger , J. M., Beecher , H. K. (1954) A study of the placebo response. American Journal of Medicine, 16, 770–779.

  • Lees -Haley , P. R., Brown , R. S. (1992) Biases in perception and reporting following a perceived toxic exposure. Perceptual and Motor Skills, 75, 531–544.

  • Levine , R. J. (1987) The apparent incompatibility between informed consent and placebo-controlled clinical trials. Clinical Pharmacology and Therapeutics, 42, 247–249.

  • Linton , H. B., Langs , R. J. (1962) Placebo reactions in a study of lysergic acid diethylamide. Archives of General Psychiatry, 6, 369–383.

  • Lipowski , Z. J. (1988) Somatization: the concept and its clinical application. American Journal of Psychiatry, 145, 1358–1368.

  • Loftus , E. F., Fries , J. F. (1979) Informed consent may be hazardous to health. Science, 204, 11.

  • Maslow , A. H. (1970) Motivation and personality . Harper and Row, New York

  • McNair , D. M., Gardos , G., Haskell , D.S., Fisher , S. (1979) Placebo response, placebo effect, and two attributes. Psychopharmacology, 63, 245–250.

  • Mechanic , D. (1972) Social psychological factors affecting the presentation of bodily complaints. New England Journal of Medicine, 286, 1132–1139.

  • Miller , D. T. (1978) What Constitutes a Self-Serving Attributional Bias? A Reply to Bradley. Journal of Personality and Social Psychology, 36 (11), 1221–1223.

  • Miller , D. T., Ross , M. (1975) Self-serving biases in the attribution of casuality: fact or fiction? Psychological Bulletin, 52, 213–225.

  • Mintz , D. (2002) Meaning and medication in the care of treatment-resistant patients. American Journal of Psychoterapy, 56, 322–337.

  • Morselli , P. L., Garattini , S. (1970) Monosodium glutamate and the chinese restaurant syndrome. Nature, 227, 611–612.

  • Myers , M. G., Cairns , J. A., Singer , J. (1987) The consent form as a possible cause of side effects. Clinical Pharmacology and Therapeutics, 42, 250–253.

  • Olshansky , B. (2007) Placebo and Nocebo in Cardiovascular Health. Journal of the American College of Cardiology, 49, 415–421.

  • Pennebaker , J. W., Burnam , M. A., Schaeffer , M. A., Harper , D. C. (1977) Lack of Control as a Determinant of Perceived Physical Symptoms. Journal of Personality and Social Psychology, 35 (3), 167–174.

  • Pennebaker , J. W., Lightner , J. M. (1980) Competition of internal and external information in an exercise setting. Journal of Personality and Social Psychology, 39, 165–174.

  • Pennebaker , J. W., Skelton , J. (1981) Selective monitoring of bodily sensations. Journal of Personality and Social Psychology, 41, 213–223.

  • Pennebaker , J. W. (1982) The psychology of Physical Symptoms . Springer, New York

  • Pennebaker , J. W. (1994) Psychological bases of symptom reporting – perceptual and emotional aspects of chemical-sensitivity. Toxicology and Industrial Health, 10 (4–5), 497–511.

  • Pilling J. (2004) Rossz hírek közlése. In Pilling J. (szerk.) Orvosi kommunikáció . 391–412. Medicina, Budapest

  • Pogge , R. C. (1963) The toxic placebo. Part I – Side and toxic effects reported during the administration of placebo medicine. Medical Times, 91 (8), 1–6.

  • Preston , R. A., Barry , J. M., Reda , D. J., Williams , D. W. (2000) Placebo-Associated Blood Pressure Response and Adverse Effects in the Treatment of Hypertension. Archives of Internal Medicine, 160, 1449–1454.

  • Reeves , R. R., Ladner , M. E., Hart , R. H., Burke , R. S. (2007) Nocebo effects with antidepressant clinical drug trial placebos. General Hospital Psychiatry, 29, 275–277.

  • Reidenberg , M. M., Lowenthal , D. T. (1968) Adverse nondrug reactions. The New England Journal of Medicine, 279, 678–679.

  • Rickels , K. (1965) Some comments on non-drug factors in psychiatric therapy. Psychosomatics, 6, 303–309.

  • Rickels , K., Downing , R. (1967) Drug- and placebo-treated neurotic outpatients. Archives of General Psychiatry, 16, 369–372.

  • Rolle -Kampczyk , U., Diez , U. (2003) Impairment of health through mould and mildew exposure in the home. Tagliche praxis, 44, 211–219.

  • Rosenzweig , P., Brohier , S., Zipfel , A. (1993) The placebo effect in healthy volunteers: influence of experimental conditions on the adverse events profile during phase I studies. Clinical Pharmacology and Therapeutics, 54 (5), 578–583.

  • Ross , M., Olson , J. M. (1981) An expectancy-attribution model of the effects of placebos. Psychological Review, 88, 408–437.

  • Schachter , S., Singer , J. (1962) Cognitive, social and physiological determinants of emotional state. Psychological Review, 69, 379–399.

  • Schweiger , A., Parducci , A. (1981) Nocebo: the psychologic induction of pain. The Pavlovian Journal of Biological Science, 16 (3), 140–143.

  • Shapiro , A. K., Mike , V., Barten , H., Shapiro , E. (1973) Study of the placebo effect with a self-administered placebo test. Comprehensive Psychiatry, 14, 535–548.

  • Shapiro , A. K., Shapiro , E. (1997) Summary and conclusions. In Shapiro , A. K., Shapiro , E. (eds) The powerful placebo . 228–237. The John Hopkins University Press, Baltimore–London

  • Shapiro , A. K., Struening , E. L., Shapiro , E. (1980) The reliability and validity of a placebo test. Journal of Psychiatric Research, 15, 253–290.

  • Shapiro , A. K., Wilensky , H., Struening , E. L. (1968) Study of the placebo effect with a placebo test. Comprehensive Psychiatry, 9, 118–137.

  • Shea , S. C. (2006) Improving medication adherence . Lippincott Williams & Wilkins, Philadelphia

  • Siegel , S. (1999) Multiple chemical sensitivity as a conditional response. Toxicology and Industrial Health, 15 (3–4), 323–330.

  • Siegel , S., Baptista , M. A. S., Kim , J. A., McDonald , R. V., Weise -Kelly , L. (2000). Pavlovian psychopharmacology: The associative basis of tolerance. Experimental and Clinical Psychopharmacology, 27, 125–136.

  • Siegel , S., Kreutzer , R. (1997) Pavlovian conditioning and multiple chemical sensitivity. Environmental Health Perspectives, 105 (Suppl. 2.), 521–526.

  • Sigaudo , M., Vighetti , S., Benedetti , F., Colloca , L. (2007) The nocebo effect: How stress modulates pain. European Psychiatry, 22, S270.

  • Smith , S., Henderson , M. (2000) What you don't know won't hurt you. Information given to patients about the side-effects of antipsychotic drugs. Psychiatric Bulletin, 24, 172–174.

  • Spiegel , H. (1997) Nocebo: the power of suggestibility. Preventive Medicine, 26, 616–621.

  • Spriet , A., Spriet , C., Larousse , C., Chigot , D., Roux , M., Simon , P. (1977) Methodology and results of a survey of adverse reactions to a drug in private practice. European Journal of Clinical Pharmacology, 11, 181–192.

  • Spurgeon , A., Gompertz , D., Harrington , J. M. (1996) Modifiers of non-specific symptoms in occuptaional and environmental syndromes. Occupational and Environmental Medicine, 53, 361–366.

  • Staats , P. S., Staats , A., Hekmat , H. (2001) The Additive Impact of Anxiety and a Placebo on Pain. Pain Medicine, 2, 267–279.

  • Ströhle , A. (2000) Increased response to a putative panicogenic nocebo administration in female patients with panic disorder. Journal of Psychiatric Research, 34, 439–442.

  • Surtees , S. J., Stockton , M. G., Gietzen , T. W. (1991) Allergy to penicillin: fable or fact? British Medical Journal, 302, 1051–1052.

  • Szegedi , V., Bárdos , Gy ., Détári , L., Tóth , A., Banczerowski -Pelyhe , I., Világi , I. (2005) Transient alterations in neuronal and behavioral activity following bensultap and fipronil treatments of rats. Toxicology, 214, 67–76.

  • Szondy M. (2006) Optimizmus és egészség. Magyar Pszichológiai Szemle, 61 (4), 617–636.

  • Tangrea , J. A., Adrianza , M. E., Helsel , W. E. (1994) Risk factors for the development of placebo adverse reactions in a multicenter clinical trial. Annals of Epidemiology, 4 (4), 327–331.

  • The Treatment of Mild Hypertension Group (1991) The treatment of mild hypertension study. Archives of Internal Medicine, 151, 1413–1423.

  • Thompson , W. G. (2005) Placebo effect and health: Combining science with compassionate care . Prometheus Books, Amherst, MA

  • Thomson , R. (1982) Side effects and placebo amplification. British Journal of Psychiatry, 140, 64–68.

  • ThuróczyGy . (2002) A rádiófrekvenciás sugárzások egészségügyi kérdései. Magyar Tudomány, 8, 1010.

  • Uhlenhuth , E., Alexander , P. E., Dempsey , G. M., Jones , W., Coleman , B. S., Swiontek , A. M. (1998) Medication side effects in anxious patients: Negative placebo responses? Journal of Affective Disorders, 47, 183–190.

  • Ursin , H. (1997) Sensitization, Somatization, and Subjective Health Complaints. International Journal of Behavioral Medicine, 4, 105–116.

  • Varga K. (2006) Placebó és szuggesztió – a gyógyítás szolgálatában. Magyar Pszichológiai Szemle, 61 (4), 597–616.

  • Weary , G. (1979) Self-Serving Attributional Biases: Perceptual or Response Distortions? Journal of Personality and Social Psychology, 37 (8), 1418–1420.

  • White , R. W. (1959) Motivation reconsidered. The concept of competence. Psychological Review, 66, 297–333.

  • Whitehead , W. E., Busch , C. M., Heller , B. R., Costa , P. T. Jr . (1986) Social learning influences on menstrual symptoms and illness behavior. Health Psychology, 5, 13–23.

  • Whitehead , W. E., Fedoravicius , A. S., Blackwell , B., Wooley , S. (1979) A behavioral conceptualization of psychosomatic illness: Psychosomatic symptoms as learned responses. In McNamara , J. R. (ed.) Behavioral Approaches in Medicine: Application and Analysis . 65–99. Plenum Press, New York

  • Whitehorn , J. C. (1958) Psychiatric implications of the “placebo effect.” American Journal of Psychiatry, 114, 662–664.

  • Willer , J. C., Dehen , H., Cambier , J. (1981) Stress-induced analgesia in humans: endogenous opioids and naloxone-reversible depression of pain reflexes. Science, 212, 689–691.

  • Williams , C. W., Lees -Haley , P. R., Price , J. R. (1998) Self-Attention and Reported Symptoms: Implications for Forensic Assessment. Professional Psychology: Research and Practice, 29 (2), 125–129.

  • Wolf , S. (1950) Effects of suggestion and conditioning on the action of chemical agents in human subjects – the pharmacology of placebos. Journal of Clinical Investigation, 29, 100–109.

  • Wolf , S., Pinsky , R. H. (1954) Effects of placebo administration and occurrence of toxic reactions. Journal of the American Medical Association, 155, 339.

All Time Past Year Past 30 Days
Abstract Views 43 43 2
Full Text Views 18 12 0
PDF Downloads 14 10 0